Measuring the impact of new housing programs on HIV risk and drug use.
Official title: Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
Funded at Brandeis University · NIH-10831058 · Data updated 2026-11-12
This study is looking at how new housing programs in Boston can help people experiencing homelessness stay healthier and safer, especially regarding HIV and drug use, by providing important resources like clean syringes and naloxone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brandeis University NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $207,369 |
| NIH project number | 5R21DA058581-02 |
| Project ID | NIH-10831058 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing homelessness who are at risk for HIV and substance use issues.
✕Less likely to help
Patients who are not experiencing homelessness or who do not have substance use issues may not benefit from this research.
What this research studies
This research investigates how novel harm reduction housing programs in Boston affect the health and safety of individuals experiencing homelessness, particularly in relation to HIV risk, treatment uptake, and drug use. By utilizing a mixed methods approach, the study aims to gather data on the experiences of residents in these housing programs, which provide essential resources like sterile syringes and naloxone. The research will analyze both the positive and negative outcomes of these interventions, focusing on how different housing models influence health behaviors and access to care.
Why it matters
Potential benefit: If successful, this research could lead to improved housing strategies that enhance health outcomes for individuals at risk of HIV and substance use disorders.
How similar studies have gone: Previous research has shown mixed results regarding the effectiveness of harm reduction strategies, indicating both potential benefits and challenges, making this study particularly relevant.
Where this research is happening
-
Brandeis University
Waltham, United States Active
Researchers
- Principal investigator: Green, Traci C — Brandeis University
- Study coordinator: Green, Traci C
Related research
Other NIH-funded projects on the same topics.
-
Couples-based motivational interviewing to reduce drug use and HIV risk in vulnerable male couples
A couples-focused program helps at-risk male couples reduce drug use and HIV risk together.
-
How growing up poor in rural Georgia affects children's brains and risk for drug use
This project looks at how early poverty and stress in rural Georgia change children's brain systems and their later chances of using drugs.
-
Understanding why teens relapse after treatment and how to keep them safe
A teen-focused study will look at why adolescents who finish inpatient treatment sometimes return to high-risk drug use and how that affects overdose risk.
-
Peer-led intervention to spread overdose prevention and support quitting opioids in high-risk communities
A randomized trial will test a peer-education program to reduce overdoses and help people who use opioids start or stay in treatment, by using social networks and new withdrawal-focused strategies.
-
High-Dose Medications for Opioid Use Disorder and Retention in Care
This project tests whether adjusted, higher-dose MOUD regimens can help people stay in treatment and reduce overdose risks during the fentanyl crisis.
-
OVAL: How laws about drug use in pregnancy affect pregnant and new mothers who use drugs
A nationwide project is looking at how laws about drug use in pregnancy influence health for pregnant and postpartum women who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.